Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 21, 2010; 16(43): 5447-5451
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5447
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5447
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
Sylvia Brost, Wolfgang Stremmel, Christoph Eisenbach, Department of Gastroenterology and Infectious Diseases, University of Heidelberg, 69120 Heidelberg, Germany
Paul Schnitzler, Department of Infectious Diseases, Virology, University of Heidelberg, 69120 Heidelberg, Germany
Author contributions: Brost S was involved in the conception of the study, collected and interpreted clinical data, and helped to draft the manuscript; Schnitzler P made the blood samples available, carried out all virological tests and revised the manuscript; Stremmel W was involved in the conception of the study and revised it critically; Eisenbach C designed and coordinated the study, and drafted the manuscript; all authors read and approved the final manuscript.
Correspondence to: Dr. Christoph Eisenbach, PD, Department of Gastroenterology and Infectious Diseases, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. christoph_eisenbach@med.uni-heidelberg.de
Telephone: +49-6221-568825 Fax: +49-6221-566858
Received: June 17, 2010
Revised: July 24, 2010
Accepted: July 31, 2010
Published online: November 21, 2010
Revised: July 24, 2010
Accepted: July 31, 2010
Published online: November 21, 2010
Core Tip